Japanese company profile · 3401
TEIJIN LIMITED
In its FY2025 public filing, TEIJIN LIMITED reports Materials, Textiles and Products, Healthcare. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 帝人株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
- Company profit
- −¥70.71B ↗ FY2025 · fiscal year ended March 2026
What does this company do?
What does this company do?
TEIJIN LIMITED's largest reported business by revenue in FY2025 was Textiles and Products.
The business with the highest reported segment profit in FY2025 was Textiles and Products.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Revenue from external customers | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Textiles and Products | ¥350.07B ↗ | 40.1% | ¥17.09B ↗ |
| Materials | ¥338.58B ↗ | 38.8% | ¥118M ↗ |
| Healthcare | ¥138.56B ↗ | 15.9% | ¥13.43B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Materials
- マテリアル
- Textiles and Products
- 繊維・製品
- Healthcare
- ヘルスケア
- Materials
- マテリアル
- Healthcare
- ヘルスケア
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Materials
- マテリアル
- Textiles and Products
- 繊維・製品
- Healthcare
- ヘルスケア
- Materials
- マテリアル
- Healthcare
- ヘルスケア
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Reported Revenue from external customers by business over time
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Materials | — | — | — | ¥459.32B | ¥338.58B |
| Textiles and Products | — | — | — | ¥351.92B | ¥350.07B |
| Healthcare | — | — | — | ¥136.97B | ¥138.56B |
| Materials | ¥385.11B | ¥456.03B | ¥439.69B | — | — |
| Healthcare | ¥183.56B | ¥152.38B | ¥144.7B | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
No comparable reported revenue growth is available.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YCMK
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.